$SMCI

Momentum Stocks to Buy and Sell: SMCI, DaVita, Insight Enterprises Analysis - News and Statistics

This article analyzes three momentum stocks, recommending one Buy and two Sells based on recent performance and underlying financial health. Super Micro Computer (SMCI) is rated a Buy due to significant revenue and EPS growth, while DaVita (DVA) and Insight Enterprises (NSIT) are flagged as Sells due to concerns over flat growth, increased capital intensity, and lagging EPS growth, despite recent stock price gains.

Original reporting
Published May 21, 2026, 10:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 21, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Momentum Stocks to Buy and Sell: SMCI, DaVita, Insight Enterprises Analysis - News and Statistics — source image
Decision brief

The 30-second read

$SMCIBullishMed
01

Why it matters

The analysis suggests a cautious approach for DVA and NSIT, while favoring SMCI for short to medium-term gains.

02

Market read

The focus on technology stocks indicates sector-specific momentum, with potential spillover effects into related industries.

03

What to watch

Potential upcoming earnings surprises or macroeconomic developments could alter current sentiment and technical signals.

Timing: Immediate to short-term (next 1-3 months)

Background

The article analyzes recent momentum stocks, highlighting strong performance in SMCI and concerns in DVA and NSIT.

Company-level read

Ticker impact

$SMCIBullishHigh confidence
Context

High relevance due to recent positive performance and strong financial growth.

Expected impact

Expected moderate upward price movement (~5-8%) over the next 1-3 months.

Evidence & confidence

Strong recent earnings reports, positive analyst sentiment, and technical indicators support bullish outlook.

$DVABearishMedium confidence
Context

Moderate relevance; despite recent stock gains, underlying concerns reduce trading impact.

Expected impact

Potential for slight decline (~3-5%) if concerns materialize, but recent gains may provide short-term support.

Evidence & confidence

Mixed technical signals and fundamental concerns suggest cautious approach; recent price gains could be temporary.

$NSITBearishMedium confidence
Context

Moderate relevance; recent stock gains are overshadowed by flat growth and EPS concerns.

Expected impact

Likely sideways movement or slight decline (~2-4%) in near term.

Evidence & confidence

Fundamental concerns and technical indicators point to limited upside, with risk of correction.

Market effects

Technology sector may experience mixed reactions; strong growth in hardware and enterprise solutions could bolster related stocks.

Limited regional impact; focus remains on US-listed stocks.

Moderate; US market movements could influence global tech indices, but specific impact is limited.

Counterpoint

DVA and NSIT may rebound if fundamental concerns are overblown, especially if broader market remains bullish.

Key entities

  • Super Micro Computer

    A technology company specializing in server and storage solutions.

  • DaVita

    A healthcare company providing kidney dialysis services.

  • Insight Enterprises

    An IT solutions provider.

Related articles

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.

$SMCIHighAI 9/10

SMCI Stock Tumbles After-Hours Following $7B Stock Offering To Fund $39B AI Order Backlog

Super Micro Computer (SMCI) shares fell nearly 10% after hours after it announced a $7 billion equity and equity-linked financing to fund its AI order backlog. The company said it received about $39 billion in orders from 20+ customers. It plans $1.25 billion common stock, $3.75 billion depositary shares, and a $2 billion ATM program, with J.P. Morgan, Goldman Sachs, and Citi as lead managers.

$DVAMed

Why is DaVita stock up 2% today?

DaVita HealthCare Partners (DVA) rose about 2.1% in pre-open trading after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and MOTheR trial results. The upgrade followed DaVita’s Q2 2026 beat, with adjusted EPS of $4.02 vs $3.92 and revenue of about $3.55B vs forecasts, despite flat guidance.

$DVAMed

DaVita Inc. Q2 2026 Earnings Call Summary

DaVita reported Q2 2026 updates on dialysis operations, citing improved patient mortality and a Medicare bundle shift that reduced reliance on OTC phosphate binders by over 50%. Revenue per treatment fell sequentially. DaVita reconfirmed 2026 adjusted operating income guidance of $2.2B and expects 2026 treatment growth at the top of 25-50 bps. FDA approval of NIPRO expanded HD dialyzers may improve supply.

$SMCIMed

One Man Allegedly Helped Smuggle $2.5 Billion Worth of AI Chips to China... And It Shows Just How Valuable Artificial Intelligence Has Become.

In March 2026, U.S. federal prosecutors arrested Yih-Shyan “Wally” Liaw, a co-founder of Super Micro Computer, alleging he helped divert $2.5 billion of AI servers with advanced Nvidia chips to China via a Southeast Asia company, allegedly bypassing U.S. export rules. Super Micro was not charged and said it cooperated, placed employees on leave, and removed Liaw from its board; its stock fell after the case became public.